Drug intelligence / Profile preview

curdlan

Development stage
Discontinued
Administration
Intraperitoneal, Subcutaneous
01

Overview

Curdlan is a high-molecular-weight linear polysaccharide consisting of beta-(1,3)-linked glucose residues, produced by the bacterium *Alcaligenes faecalis* var. *myxogenes*. In biomedical research, it is primarily utilized as a potent pharmacological tool to induce systemic inflammation and autoimmune-like conditions in specific animal models, most notably the SKG mouse model of spondyloarthritis. Curdlan acts as a specific agonist for **Dectin-1** (C-type lectin domain family 7 member A), a pattern recognition receptor predominantly expressed on myeloid cells such as macrophages and dendritic cells. Activation of the Dectin-1 pathway by curdlan triggers the production of pro-inflammatory cytokines, particularly the IL-23/IL-17 axis, which leads to the development of peripheral arthritis, spinal inflammation, and eventual ankylosis. Beyond its use as a research reagent, curdlan is employed in the food industry as a gelling agent, thickener, and stabilizer due to its unique ability to form elastic gels upon heating.

Other names
beta-1,3-glucancurdlan gumE424E-424E 424
02

Targets

CLEC7A (Dectin-1)

Beyond the preview

Go deeper on curdlan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on curdlan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call